U.S. markets open in 1 hour 35 minutes

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.35-0.31 (-2.91%)
At close: 4:00PM EST

10.34 -0.01 (-0.10%)
Pre-Market: 7:09AM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 3/2/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 39.06%
S&P500 52-Week Change 326.78%
52 Week High 325.39
52 Week Low 36.25
50-Day Moving Average 316.72
200-Day Moving Average 318.19

Share Statistics

Avg Vol (3 month) 34.01M
Avg Vol (10 day) 35.05M
Shares Outstanding 5264.32M
Float 215.91M
% Held by Insiders 10.56%
% Held by Institutions 1108.02%
Shares Short (Feb 11, 2021) 431.1M
Short Ratio (Feb 11, 2021) 46.91
Short % of Float (Feb 11, 2021) 411.94%
Short % of Shares Outstanding (Feb 11, 2021) 411.87%
Shares Short (prior month Jan 14, 2021) 427.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin -106.12%
Operating Margin (ttm)-93.47%

Management Effectiveness

Return on Assets (ttm)-17.55%
Return on Equity (ttm)-72.59%

Income Statement

Revenue (ttm)260.89M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)27.60%
Gross Profit (ttm)229.84M
EBITDA -235.01M
Net Income Avi to Common (ttm)-276.85M
Diluted EPS (ttm)-1.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)483.27M
Total Cash Per Share (mrq)1.83
Total Debt (mrq)441.73M
Total Debt/Equity (mrq)154.25
Current Ratio (mrq)4.47
Book Value Per Share (mrq)1.09

Cash Flow Statement

Operating Cash Flow (ttm)-233.29M
Levered Free Cash Flow (ttm)-137.55M